Medical Innovation Prize Fund Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,805 other S bills in the 115th — cohort avg 41d
Medical Innovation Prize Fund Act This bill denies any person the exclusive right to manufacture, distribute, sell, or use a drug, a biological product, or a medication manufacturing process. The bill establishes the Fund for Medical Innovation Prizes to provide for prize payments in lieu of market exclusivity. The Board of Trustees of the fund must award prize payments to: (1) the first person to receive approval for a medication; (2) the holder of the patent for a manufacturing process; and (3) persons or communities that contributed to the development of a rewarded medication or process through the open, nondiscriminatory, and royalty-free sharing of knowledge, data, materials, and technology. The board must establish: (1) criteria for selecting recipients and determining the amount of prizes, and (2) independent expert advisory committees to assist it in carrying out this bill. The board must establish, and may periodically modify, minimum levels of funding for priority research and development, including research and development regarding global neglected diseases, orphan diseases, global infectious diseases, and other global public health priorities. The board may authorize nonprofit intermediaries to reward projects for interim research and development of products or for open source dividend prizes. The Government Accountability Office must determine the board's effectiveness in bringing to market new medications and manufacturing processes in a cost-effective manner and in addressing society's medical needs. The bill establishes an annual fee on health insurers to fund this bill.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · fourth_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2024 · third_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs
Client expense: $890,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2024 · second_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs
Client expense: $1,020,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2024 · first_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs
Client expense: $990,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2023 · fourth_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs
Client expense: $1,340,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2023 · third_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs
Client expense: $990,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2023 · second_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs
Client expense: $920,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2023 · first_quarter · Veterans
Outreach to VA and DOL: VA Provider Agreements, PDPM, IDIQ, and Community Care Network (CNN) Implementation AHCA is working with the VA on implementation of the provider agreement section of the VA Mission Act of 2018 VA contracts and federal contracting minimum wage - outreach to VA, DOL, & the Hill S.495/H.R.1815 - The Expanding Veterans Options for Long Term Care Act Outreach to the VA on VCAs and CCNs
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Veterans Affairs, Dept of (VA)
2018 · second_quarter · Pharmacy
S 2011/HR 4138-Medicare Drug Price Negotiation Act, S 974/HR 2212-CREATES Act of 2017, S 124-Preserve Access to Affordable Generics Act, HR 1625-OMNIBUS, opioid addiction data analysis, S 771-Improving access to affordable prescription drugs act, S 252-Medicare Drug Savings act of 2017, S 1369-Stop Price Gouging Act, S 495-Medical innovation and prize fund act, S 1131/HR 2439-FAIR drug pricing act, HR 4117-Competitive Drugs act of 2017, S 771/HR 1776-Improving access to affordable prescription drugs act, S 637-C-THRU Act, S 1347-RxCap Act of 2017, S 1348-SPIKE Act of 2017, HR 5156-Protecting Medicare from Excessive Price Increases Act of 2018, S 2691-Opioid Crisis accountability act of 2018, S 2315-Over the counter drug safety, innovation, and reform act, S 2700/HR 5545-Comprehensive Addiction Resources Emergency (CARE) act, Drug Pricing-Medicare Part D HR 2051-FAST Generics Act of 2017, HR 4116-Transparent Drug Pricing Act, S 2852-Pandemic and All-Hazards Preparedness Act and advancing innovative Act of 2018,
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
2018 · first_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017 S 469 Affordable and Safe Prescription Drug Importation Act S 2553 Know the Lowest Price Act of 2018 -- prohibits health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals S 2554 Patient Right to Know Drug Prices Act -- ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees
Client expense: $34,000 · Firm income: Not reported
2018 · first_quarter · Pharmacy
S. 771/HR 1776-Improving access to affordable Prescription Drugs act, S 2157-Drug Price transparency in Communications Act, S 2011/HR 4138-Medicare drug price negotiation act of 2017, S 1688-Empowering medicare seniors to negotiate drug prices of 2017, S 252-Medicare drug savings act of 2017, S 1369/HR 2974-Stop Price gouging act, S 124-Preserve access to affordable generics act, S 974/HR 2212-CREATES Act of 2017, S 495-Medical Innovation and Prize Fund Act, S 1131/HR 2439-FAIR drug pricing act, Over-the-counter Monograph Safety, Innovation, and Reform Act of 2018, HR 4117-Competitive DRUGS Act of 2017), HR 2051- FAST Generics Act of 2017), Prescription drug pricing, PACED Act, S 771/HR 1776 (Improving access to affordable prescription drugs act, S 1509/HR 1223 OPEN Act), S 1309-Stronger patents act, HR 5150 Protecting Medicare from excessive price increases act, S 2476-Expanding access to low cost generics act, S 637 (c-thru act), S 1348-SPIKE act,
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
2017 · fourth_quarter · Pharmacy
S 771/HR1776-Improving access to affordable prescription drugs act, S 2011/HR 4138-Medicare Price Negotiation Act of 2017, S 252-Medicare Drug Savings Act of 2017, S 1369/HR 2974-Stop Price Gouging Act, S 124-Preserve access to affordable generics act, HR 4117-Competitive DRUGS Act of 2017, S 974/HR 2212-CREATES act of 2017, HR 2051-FAST generics Act of 2017, S 495-Medicare Innovation Prize Fund Act, S 1131.HR 2439-FAIR Drug Pricing act, HR 4116-Transparent Drug Pricing Act of 2017, S 1509-Orphan Products extension accelerating cures and treatments, HR 1223-OPEN act, S 1390-Stronger Patriots Act of 2017, S 1827-KIDS Act of 2017, HR 1628-American Health care act of 2017, HR 3921-Healthy KIDS Act, HR 4116-Transparent drug pricing act of 2017, Bipartisan Health Care Stabilization Act of 2017, biologic market exclusivity, inter partes review, direct to consumer advertising, Over-the-counter Monograph Safety Innovation and Reform act of 2017, Azar HHS nomination,
Client expense: $70,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Education, Dept of, Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Government Ethics (OGE), SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR), White House Office
2017 · fourth_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017 S 469 Affordable and Safe Prescription Drug Importation Act
Client expense: $34,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017 S 469 Affordable and Safe Prescription Drug Importation Act
Client expense: $34,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Pharmacy
S 934/HR 2430-FDA re-authorization Act of 2017, S 974/HR 2212-CREATES Act, S 771/HR 1776-Improving access to affordable prescription drugs act, S 204-Trickett Wendler Right to try act of 2017, S 1509/HR 1223-OPEN act, S 1369/HR 2974-Stop Price Gouging Act, Preserve access to affordable generics act, HR 205-to amend the Food, Drug & Cosmetic Act to require labeling of genetically engineered fish, S 495-Medicaid Innovation Price Fund Act, S 252-Medicaid Drug Savings Act of 2017,S 1131/HR 2439-Fair Accountability and Innovative Research Drug Pricing Act of 2017, HR 1628-American Health Care Act of 2017, S 297-Increasing Competition in Pharmaceuticals Act, HR 749 Lower drugs through Competition act, S 1390-stronger patents act of 2017, S 168/HR 3536-A bill to require persons who undertake federally funded research and development of drugs to enter into reasonable pricing agreements with Secretary of HHS.
Client expense: $70,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
2017 · second_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Housing
H.R. 101, Home Foreclosure Reduction Act of 2015 H.R. 189, Service member Foreclosure Protections Extension Act of 2015 H.R. 190, Making Service member Foreclosure Protections Permanent Act H.R. 233, Tenant Income Verification Relief Act of 2015 H.R. 574, To prohibit contributions by Fannie Mae and Freddie Mac to the Housing Trust Fund and the Capital Market Fund while such enterprises are in conservatorship or receivership, and for other purposes H.R. 576, To amend the definition of "homeless person" under the McKinney-Vento Homeless Assistance Act to include certain homeless children and youth, and for other purposes. H.R. 650, To amend the Truth in Lending Act to modify the definitions of a mortgage originator and a high-cost mortgage H.R. 1001, To amend the Internal Revenue Code of 1986 to terminate certain energy tax subsidies and lower the corporate income tax rate H.R. 1297, To amend the Robert T. Stafford Disaster Relief and Emergency Assistance Act to provide assistance for housing cooperatives damaged by a major disaster, to provide relief to homeowners affected by major disasters who have mortgages insured by the FHA or owned or guaranteed by Fannie Mae or Freddie Mac, and for other purposes H.R. 1354, Permanently Protecting Tenants at Foreclosure Act of 2015 H.R. 1491, Partnership to Strengthen Homeownership Act of 2015 H.R. 1577, Fannie Mae and Freddie Mac Transparency Act of 2015 H.R. 3700, Housing Opportunity Through Modernization Act of 2016 S. 65, Moving to Work Charter Program Act of 2015 S. 256, Homeless Children and Youth Act of 2015 S. 351, A bill to prevent homeowners from being forced to pay taxes on forgiven mortgage loan debt S. 495, A bill to revoke the charters for the Federal National Mortgage Corporation and the Federal Home Loan Mortgage Corporation upon resolution of their obligations, to create a new Mortgage Finance Agency for the securitization of single family and multifamily mortgages, and for other purposes S. 730, Permanently Protecting Tenants at Foreclosure Act of 2015 S.752, A bill to establish a scorekeeping rule to ensure that increases in guarantee fees of Fannie Mae and Freddie Mac shall not be used to offset provisions that increase the deficit
2017 · first_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245, S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $27,003 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE